Liu PT, Stenger S, Tang DH, Modlin RL. \nCutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin.\nJ Immunol. 2007 Aug 15;179(4):2060-3.\nPMID: 17675463 [PubMed - in pr

Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge SM, Maunsell ZJ, Rainbow SJ, Berry JL, Griffiths CJ. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007

In healthy people who have been exposed to tuberculosis, a single oral dose of vitamin D enhances their immunity against this bacterial infection.

Faiz S, Panunti B, Andrews S. \nThe epidemic of vitamin D deficiency.\nJ La State Med Soc. 2007 Jan-Feb;159(1):17-20; quiz 20, 55.\nPMID: 17396471 [PubMed - in process]

Grant WB, Garland CF, Gorham ED. \nAn estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day.\nRecent Results Cancer Res. 2007;174:225-34.\nPMID: 17302200 [PubMed - in process]

Valimaki VV, Loyttyniemi E, Valimaki MJ.\nVitamin D fortification of milk products does not resolve\nhypovitaminosis D in young Finnish men.\nEur J Clin Nutr. 2006 Nov 29; [Epub ahead of print]\nPMID: 17136043 [PubMed - as supplied by publisher]

Valimaki VV, Alfthan H, Lehmuskallio E, Loyttyniemi E, Sahi T, Stenman UH, Suominen H, Valimaki MJ.\nVitamin D status as a determinant of peak bone mass in young Finnish men.\nJ Clin Endocrinol Metab. 2004 Jan;89(1):76-80.\nPMID: 14715830 [PubMed - indexe

Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. \nVitamin D in the treatment of pulmonary tuberculosis.\nJ Steroid Biochem Mol Biol. 2007 Mar;103(3-5):793-8. Epub 2007 Jan 12. Review.\nPMID: 17223549 [PubMed - indexed for MEDLINE]

van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ. \nVitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.\nJ Neurol. 2007 May;254(5):581-90. Epub 2007 Apr 11.

Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P. \nVitamin D status predicts physical performance and its decline in older persons.\nJ Clin Endocrinol Metab. 2007 Jun;92(6):2058-65. Epub 2007 Mar 6.\nPMID: 17341569 [PubMed

Reginster JY. \nPrevalence of vitamin D inadequacy in European postmenopausal women.\nCurr Med Res Opin. 2007 Jul 12; [Epub ahead of print]\nPMID: 17631697 [PubMed - as supplied by publisher]

Gonzalez G, Alvarado JN, Rojas A, Navarrete C, Velasquez CG, Arteaga E. \nHigh prevalence of vitamin D deficiency in Chilean healthy postmenopausal women with normal sun exposure: additional evidence for a worldwide concern.\nMenopause. 2007 May-Jun;14(3

High dietary menaquinone intake is associated with reduced coronary calcification.\nBeulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, Witteman JC, Grobbee DE, van der Schouw YT.\nAtherosclerosis. 2008 Jul 19. [Epub ahead of print]\nPMID: 18722618 \ndoi:10.1016/j.atherosclerosis.2008.07.010 \n

Dietary supplementation with fermented soybeans suppresses intimal thickening. Suzuki Y, Kondo K, Ichise H, Tsukamoto Y, Urano T, Umemura K. Nutrition. 2003 Mar;19(3):261-4. PMID: 12620531

Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women.\nKatsuyama H, Ideguchi S, Fukunaga M, Fukunaga T, Saijoh K, Sunami S.\nJ Nutr Sci Vitaminol (Tokyo). 2004 Apr;50(2):114-20.\nPMID: 15242015

Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.\nSchurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C.\nBlood. 2007 Apr 15;109(8):3279-83. Epub 2006 Dec 7.\nPMID: 17158229 \nDOI 10.1182/blood-2006-08-040709\n

Vitamin K has been known as the coagulation vitamin, because of its role in the blood-clotting process. However, research over the last few decades has shown that the role of K Vitamins - and natural Vitamin K2, the menaquinones, in particular - has been greatly expanded. Of note, K Vitamins activity outside the liver is required for calcium utilization, the key factor in maintaining both bone and cardiovascular health.\n\nVitamin K2 helps to activate vitamin K-dependent proteins responsible for healthy tissues. In bone, it activates osteocalcin, a protein required to bind calcium to the mineral matrix, thus strengthening the skeleton. In circulation, Vitamin K2 participates in carboxylation of Matrix Gla Protein (MGP), the most potent inhibitor of arterial calcification known, lowering the risk of vascular damage.

Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).\nNimptsch K, Rohrmann S, Linseisen J.\nAm J Clin Nutr. 2008 Apr;87(4):985-92.\nPMID: 18400723

LYSAKER, Norway, April 11, 2008-An increased intake of vitamin K2 may reduce the risk of prostate cancer by 35 per cent, suggest results from the European Prospective Investigation into Cancer and Nutrition (EPIC). The findings, based on dietary intake from 11,319 men taking part in the EPIC Heidelberg cohort, are published in this month's issue of the American Journal of Clinical Nutrition.